UnitedHealth's stock price fell 51.32% from November 2024 to May 2025, then rose 40.64% by October 2026. These price moves directly influenced its weighting in the SPDR Dow Jones Industrial Average ETF (DIA), which is price-weighted. This means the fund's exposure to UnitedHealth increased when its share price rose and decreased when it fell, independent of company size or fundamentals. The price-weighting method cushions losses during declines but limits gains during rebounds. Investors should understand that DIA's holdings reflect share prices, not company size or quality, and fees are higher than broad market ETFs.
As of Oct 16, 2026 07:21 WIB, UnitedHealth (UNH) trades at USD 407.08 on Pluang, up 2.90% in the last day, with a market cap of $355.11 billion. The Dow Jones Industrial Average ETF (DIA) is priced at USD 520.71, gaining 0.98% in the same period. Despite the large historical price swings in UnitedHealth, current Pluang order activity shows 97% selling interest in UNH, contrasting with 98% buying interest in DIA, highlighting differing investor sentiment within these related assets.
UnitedHealth's stock has dropped over 10% in three months due to shrinking membership, particularly in Medicare Advantage. Despite this, Morgan Stanley raised its price target to $529, forecasting a 40% upside based on expected margin improvements, g...
UnitedHealth Group reported strong Q3 2026 results, with adjusted earnings per share of $4.69, surpassing estimates of $4.14. Revenue also exceeded expectations at $112.70 billion. The company raised its full-year outlook, reflecting solid operationa...
UnitedHealth Group reported better-than-expected Q3 2026 results, beating both revenue and earnings estimates. The company raised its full-year guidance, reflecting a turnaround driven by shedding unprofitable units and investing in efficiency and te...
UnitedHealth Group raised its 2026 earnings outlook following a 52% increase in third-quarter operating profit to $6.6 billion, driven by lower medical costs and better operational efficiency. The company now expects adjusted earnings of at least $20...
UnitedHealth shares rose 4% after beating Q3 2026 earnings estimates with adjusted EPS of $4.69 and raising its full-year outlook to at least $20.50. The earnings beat was driven by improved medical care ratio, helped partly by a $610 million reserve...
